1.86
Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.83%
0.12
|
0.121 | 0.109 | 0.165 | 0.163 |
|
|
18.82%
12.09
|
14.90 | 14.49 | 12.77 | 12.71 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
18.82%
12.09
|
14.90 | 14.49 | 12.77 | 12.71 |
| Operating Income/Loss |
18.97%
-11.97
|
-14.78 | -14.38 | -12.60 | -12.54 |
| Nonoperating Income/Loss |
14.15%
0.716
|
0.834 | 0.948 | 0.746 | 0.767 |
| Income/Loss From Continuing Operations Before Tax |
100.86%
0.12
|
-13.94 | -13.43 | 0.165 | -11.78 |
| Income/Loss From Continuing Operations After Tax |
19.26%
-11.26
|
-13.94 | -13.43 | -11.86 | -11.78 |
|
|
19.26%
-11.26
|
-13.94 | -13.43 | -11.86 | -11.78 |
| Preferred Stock Dividends And Other Adjustments |
0.006
|
- | - | 0.006 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.53%
66.88
|
66.53 | 66.52 | 46.87 | 44.83 |
| Diluted Average Shares |
0.53%
66.88
|
66.53 | 66.52 | 46.87 | 44.83 |
| Basic Earnings Per Share |
19.05%
-0.17
|
-0.21 | -0.20 | -0.25 | -0.26 |
| Diluted Earnings Per Share |
19.05%
-0.17
|
-0.21 | -0.20 | -0.25 | -0.26 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.006
|
- | - | 0.006 | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):